Latest Genencor Stories
WILMINGTON, Del., May 19, 2011 /PRNewswire/ -- DuPont (NYSE: DD) today announced the formation of two new business units, Industrial Biosciences and Nutrition & Health. The company has appointed Craig F. Binetti as the president of the new Nutrition & Health business and James C.
COPENHAGEN, Denmark, May 16, 2011 /PRNewswire/ -- DuPont (NYSE: DD), through its wholly owned subsidiary DuPont Denmark Holding ApS, announced today that it has successfully completed its tender offer for all outstanding shares of common stock of Danisco for DKK 700 cash per share.
Industry Leaders Take Newly Elected Positions on ABFA Board WASHINGTON, March 10, 2011 /PRNewswire-USNewswire/ -- The top trade groups representing the advanced biofuels industry in the United States met today in Washington, D.C.
WILMINGTON, Del., Jan. 9, 2011 /PRNewswire/ -- DuPont (NYSE: DD) has entered into a definitive agreement for the acquisition of Danisco, a global enzyme and specialty food ingredients company, for $5.8 billion in cash and assumption of $500 million of Danisco net debt.
DES MOINES, Iowa, June 28 /PRNewswire/ -- Iowa is rapidly becoming the development capital of the nation for the replacement of petroleum-based chemicals with bio-based chemicals.
Potential saving: 10 trillion liters of freshwater and 30 million metric tons of CO2 emissions per year SINGAPORE and PALO ALTO, Calif., June 28 /PRNewswire/ -- Huntsman Textile Effects and Genencor, a division of Denmark-based Danisco A/S, today announced the results of a Life Cycle Assessment (LCA) on GENTLE POWER BLEACH(TM), a bleaching system introduced into the textile pretreatment market in March 2009.
SPEZYMEÂ® RSL Improves Liquefaction, Reducing Production Costs and Increasing Ethanol Yield PALO ALTO, Calif., June 14 /PRNewswire/ -- Genencor, a division of Danisco A/S, today launched SPEZYMEÂ® Robust Starch Liquefaction (RSL) at the 2010 Fuel Ethanol Workshop and Expo (FEW) in St. Louis, Mo.
PALO ALTO, Calif., May 4 /PRNewswire/ -- "BIO has long been a strong and outspoken advocate for the critical, game-changing work of the biotechnology sector.